查菲埃立克体IgG免疫荧光玻片试剂盒

查菲埃立克体IgG免疫荧光玻片试剂盒

Ehrlichia chaffeensis IgG 120-test IFA Kit

广州健仑生物科技有限公司

主要用途：用于检测人血清中的查菲埃立克体 IgG 抗体

产品规格：12 孔/张,10 张/盒

包括包柔氏螺旋体菌、布鲁氏菌、贝纳特氏立克次体、土伦杆菌、钩端螺旋体、新型立克次体、恙虫病、立克次体、果氏巴贝西虫、马焦虫、牛焦虫、利什曼虫、新包虫、弓形虫、猫流感病毒、猫冠状病毒、猫疱疹病毒、犬瘟病毒、犬细小病毒等病原微生物的 IFA、MIF、ELISA试剂。

查菲埃立克体IgG免疫荧光玻片试剂盒

我司还提供其它进口或国产试剂盒：登革热、疟疾、流感、A链球菌、合胞病毒、腮病毒、乙脑、寨卡、黄热病、基孔肯雅热、克锥虫病、违禁品滥用、肺炎球菌、军团菌、化妆品检测、食品安全检测等试剂盒以及日本生研细菌分型诊断血清、德国SiFin诊断血清、丹麦SSI诊断血清等产品。

欢迎咨询

欢迎咨询2042552662

二维码扫一扫

【公司名称】 广州健仑生物科技有限公司
【】    杨永汉 
【】 
【腾讯 】 2042552662
【公司地址】 广州清华科技园创新基地番禺石楼镇创启路63号二期2幢101-3室
【企业文化】

研究还发现，这种抗体能够遏制胰腺癌、肺癌、抗原抗体癌、大肠癌、前列腺癌等癌细胞增殖。
研究人员指出，血液中的抗体与核糖体蛋白L29结合后，能够遏制后者的功能，使癌细胞难以分裂，从而凋亡，因此这种抗体应该就是构成人体内肿瘤免疫系统的物质之一。目前他们正在研发以这种抗体为基础的抗癌药物和疫苗。
道格拉斯·梅尔顿比任何人都急于得到糖尿病的治愈方法，因为他的儿子在还是个婴儿的时候就患有此病了，而他的女儿在14岁时被诊断出该病。在过去20年中的大多数时间，哈佛干细胞研究所的发育生物学家道格拉斯·梅尔顿一直将他的研究致力于该病的治愈方法的发现。他和他的同事在本周报告了接近这个目标的重要的一步：一个配方可以把人类干细胞转变为功能性胰岛β细胞——该细胞可被1型糖尿病患者(如梅尔顿的儿子和女儿)自身的免疫系统破坏。研究人员在本研究中转变出的胰岛β细胞通过产生胰岛素对葡萄糖作出反应，如同正常β细胞所做的。当将糖尿病的形式注入到小鼠中，该细胞可以治愈这个疾病。
“糖尿病研究界为这种类型的突破已经等了好长一段时间，” 伦敦帝国学院研究β细胞遗传的豪尔赫·费雷尔说。这个实验室生成的细胞可能会成为用于研究糖尿病的一种有价值的工具，并且梅尔顿希望，其zui终可以用来治疗患者。

The study also found that this antibody can curb pancreatic cancer, lung cancer, antigen-antibody cancer, colorectal cancer, prostate cancer and other cancer cell proliferation.
The researchers pointed out that the blood of antibodies and ribosomal protein L29 binding, the ability to contain the latter, so that cancer cells are difficult to divide, and thus apoptosis, so this antibody should constitute one of the body's tumor immune system substances. They are currently developing anti-cancer drugs and vaccines based on this antibody.
Douglas Melton is more eager than anyone to get a cure for diabetes because his son was ill when he was still a baby and his daughter was diagnosed at the age of 14. For most of the past two decades Douglas Melton, a developmental biologist at the Harvard Stem Cell Institute, has been devoting his research to the discovery of a cure for the disease. This week, he and his colleagues reported an important step closer to achieving this goal: a formula that converts human stem cells into functional islet beta cells that can be activated by type 1 diabetics (such as Melton's son and daughter Own immune system damage. The islet beta cells that the researchers transformed in this study respond to glucose by producing insulin, as does normal beta cells. When a form of diabetes is injected into mice, the cell can heal the disease.
"The diabetes community has waited for this type of breakthrough for a long time," said Jorge Ferrer, who studies beta-cell inheritance at Imperial College London. The lab-generated cells may be a valuable tool for studying diabetes and Melton hopes it can eventually be used to treat patients.